Atlas Trials

Evaluation and Validation of Endogenous Markers for the Assessment of CYP3A Activity in Korean Healthy Subjects Using Metabolomics

Clinical trial NCT02579434 · COMPLETED

Trial details

NCT number
NCT02579434
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2014-12-01
Primary completion
2015-05-01
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.